JPS61345B2 - - Google Patents

Info

Publication number
JPS61345B2
JPS61345B2 JP51139649A JP13964976A JPS61345B2 JP S61345 B2 JPS61345 B2 JP S61345B2 JP 51139649 A JP51139649 A JP 51139649A JP 13964976 A JP13964976 A JP 13964976A JP S61345 B2 JPS61345 B2 JP S61345B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51139649A
Other languages
Japanese (ja)
Other versions
JPS5277082A (en
Inventor
B G Christensen
J Hannah
W J Leanzo
R W Ratcliffe
D H M Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5277082A publication Critical patent/JPS5277082A/ja
Publication of JPS61345B2 publication Critical patent/JPS61345B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP51139649A 1975-11-21 1976-11-22 Oo nn and carboxyl derivatives of thiena mycine Granted JPS5277082A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63429475A 1975-11-21 1975-11-21

Publications (2)

Publication Number Publication Date
JPS5277082A JPS5277082A (en) 1977-06-29
JPS61345B2 true JPS61345B2 (fr) 1986-01-08

Family

ID=24543209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51139649A Granted JPS5277082A (en) 1975-11-21 1976-11-22 Oo nn and carboxyl derivatives of thiena mycine

Country Status (8)

Country Link
JP (1) JPS5277082A (fr)
CH (1) CH633554A5 (fr)
DE (1) DE2652680A1 (fr)
DK (1) DK523376A (fr)
FR (1) FR2332015A1 (fr)
GB (1) GB1570987A (fr)
NL (1) NL7612942A (fr)
SE (1) SE7612961L (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1531141A (en) * 1976-08-17 1978-11-01 Beecham Group Ltd Beta-lactam antibiotics
NL7712092A (nl) * 1976-11-17 1978-05-19 Merck & Co Inc Werkwijze ter bereiding van een nieuw antibiotisch middel.
EP0007152A1 (fr) * 1978-04-28 1980-01-23 Beecham Group Plc Antibiotiques bêta-lactames, préparation et application
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
DE2966187D1 (en) * 1978-08-23 1983-10-27 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
EP0044142A1 (fr) * 1980-07-03 1982-01-20 Beecham Group Plc Procédé de préparation d'antibiotiques bêta-lactame

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
FR2332015A1 (fr) 1977-06-17
FR2332015B1 (fr) 1978-11-10
JPS5277082A (en) 1977-06-29
SE7612961L (sv) 1977-05-22
GB1570987A (en) 1980-07-09
DK523376A (da) 1977-05-22
CH633554A5 (en) 1982-12-15
DE2652680A1 (de) 1977-06-02
NL7612942A (nl) 1977-05-24

Similar Documents

Publication Publication Date Title
FR2332014B1 (fr)
FR2332013B1 (fr)
JPS61345B2 (fr)
FR2332016B1 (fr)
AU495907B2 (fr)
JPS5528174Y2 (fr)
BG22969A1 (fr)
CH1386575A4 (fr)
CH599616B5 (fr)
CH599848A5 (fr)
AU479731A (fr)
AU481126A (fr)
CH601495A5 (fr)
AU481747A (fr)
BG21166A1 (fr)
BG21506A1 (fr)
BG21649A1 (fr)
BG21783A1 (fr)
BG22116A1 (fr)
BG22164A1 (fr)
BG22264A1 (fr)
BG22319A1 (fr)
BG22751A1 (fr)
CH598580A5 (fr)
CH600580A5 (fr)